Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking technology

Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking technology

Context In China, HUANGQI is widely used for the treatment of Alzheimer’s disease (AD). However, a comprehensive understanding of its mechanism of anti-AD effects is lacking.Objective To explore the active ingredients of HUANGQI and its potential targets and mechanisms of action in AD.Materials and...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng Lv, Mei Sun, Chunmeng Qin, Dan Du, Xiangru Zheng, Wenjun Li
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Pharmaceutical Biology
Subjects:
Anti-inflammatory
antioxidant
molecular simulation
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2024.2382962
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/13880209.2024.2382962

Similar Items